Key Metrics
4.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q2
Pharmacology (medical)
SJR
- Q2 Pharmacology (medical)
- Q1 Cardiology and Cardiovascular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
10 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
0%
4 to 6 months
0%
7 to 9 months
31%
Above 9 months
69%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Heart failure
- Tolvaptan
- Aortic valve sclerosis
- Myocardial infarction
- Ejection fraction
- Atrial fibrillation
- Galectin-3
- Percutaneous coronary intervention
- Hemodynamic effects
- Multivariate analysis
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | USD 2000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Cardiovascular Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study.
- 1 Feb 24
- Therapeutic advances in cardiovascular disease
-
Full paper
Quantifying the 'distance to LDC-goal' in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis.
- 1 Feb 24
- Therapeutic advances in cardiovascular disease
-
Full paper
Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease.
- 1 Feb 24
- Therapeutic advances in cardiovascular disease
-
Full paper
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment.
- 1 Feb 24
- Therapeutic Advances in Cardiovascular Disease
-
Full paper
Coronary intravascular lithotripsy in contemporary practice: challenges and opportunities in coronary intervention.
- 1 Feb 24
- Therapeutic advances in cardiovascular disease
-
Full paper
Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement.
- 1 Feb 24
- Therapeutic advances in cardiovascular disease
Scite analysis
Powered by scite_
483 articles received 6.8k citations see all
- 200 Supporting
- 6,117 Mentioning
- 32 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 2 Corrections
- 1 Errata
- 0 Expression of Concern
FAQs
How long has Therapeutic Advances in Cardiovascular Disease been actively publishing?
Therapeutic Advances in Cardiovascular Disease has been in operation since 2007 till date.
What is the publishing frequency of Therapeutic Advances in Cardiovascular Disease ?
Therapeutic Advances in Cardiovascular Disease published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Cardiovascular Disease publish last years ?
In 2024, Therapeutic Advances in Cardiovascular Disease published 28 articles.
What is the eISSN & pISSN for Therapeutic Advances in Cardiovascular Disease ?
For Therapeutic Advances in Cardiovascular Disease,eISSN is 1753-9455 and pISSN is1753-9447.
What is Citescore for Therapeutic Advances in Cardiovascular Disease ?
Citescore for Therapeutic Advances in Cardiovascular Disease is 4.9.
What is SNIP score for Therapeutic Advances in Cardiovascular Disease ?
SNIP score for Therapeutic Advances in Cardiovascular Disease is 1.
What is the SJR for Therapeutic Advances in Cardiovascular Disease ?
SJR for Therapeutic Advances in Cardiovascular Disease is Q2.
Who is the publisher of Therapeutic Advances in Cardiovascular Disease ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Cardiovascular Disease.